Busch, Robyn M.
Srivastava, Siddharth
Hogue, Olivia
Frazier, Thomas W.
Klaas, Patricia
Hardan, Antonio
Martinez-Agosto, Julian A.
Sahin, Mustafa http://orcid.org/0000-0001-7044-2953
Eng, Charis http://orcid.org/0000-0002-3693-5145
Warfield, Simon K.
Scherrer, Benoit
Dies, Kira
Filip-Dhima, Rajna
Gulsrud, Amanda
Hanson, Ellen
Phillips, Jennifer M.
,
Article History
Received: 17 May 2019
Revised: 4 September 2019
Accepted: 16 September 2019
First Online: 8 October 2019
Conflict of interest
: Dr. Busch has no relevant financial interests or potential conflicts of interest to report. Dr. Srivastava has no relevant financial interests or potential conflicts of interest to report. Ms. Hogue has no relevant financial interests or potential conflicts of interest to report. Dr. Frazier has received federal funding or research support from, acted as a consultant to, received travel support from, and/or received a speaker’s honorarium from the Cole Family Research Fund, Simons Foundation, Ingalls Foundation, Forest Laboratories, Ecoeos, IntegraGen, Kugona LLC, Shire Development, Bristol-Myers Squibb, Roche Pharma, National Institutes of Health, and the Brain and Behavior Research Foundation. Dr. Klaas has no relevant financial interests or potential conflicts of interest to report. Dr. Hardan has no relevant financial interests or potential conflicts of interest to report. Dr. Martinez-Agosto has no relevant financial interests or potential conflicts of interest to report. Dr. Sahin reports grant support from Novartis, Roche, Pfizer, Ipsen, LAM Therapeutics and Quadrant Biosciences, and he has served on Scientific Advisory Boards for Sage, Roche, Celgene and Takeda, all unrelated to this project. Dr. Eng has no relevant financial interests or potential conflicts of interest to report.